Anti-CTLA4 antibodies and uses thereof

US11001632B2 · kind B2 · utility

Assignee

• Eucure (Beijing) Biopharma Co., Ltd · CN

Inventors

• Yi Yan Yang · Singapore, SG
• Yanan Guo · Beijing, CN
• Xiaodong Cheng · Beijing, CN
• Yunyun Chen · Beijing, CN
• Jingshu Xie · Beijing, CN
• Chunyan Dong · Beijing, CN
• Fang Yang · Beijing, CN
• Chengyuan Lu · Beijing, CN
• Yuelei Shen · Beijing, CN
• Jian Ni · Rockville, US

Key dates

• Filing date: Mar 11, 2020
• Grant date: May 11, 2021
• Expiry date: Mar 11, 2040

Classification

• Technology area (CPC —): General

Abstract

This disclosure relates to anti-cytotoxic T-lymphocyte-associated protein 4 (CTLA4 or CTLA-4) antibodies, antigen-binding fragments, and the uses thereof.